Disease Steps for Multiple Sclerosis

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
disease step score
—step
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Normal0–0
  • Mild disability1–1
  • Moderate disability2–2
  • Early cane3–3
Direct Clinical Answer

The Disease Steps for Multiple Sclerosis calculates assessing MS disease progression based on patient's ambulatory ability. Key inputs include disease step. Scores guide initiating intravenous thrombolysis, activating endovascular thrombectomy pathways, or secondary prevention protocols. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Assesses MS disease progression based on patient's ambulatory ability

Clinical Indication

The Disease Steps for Multiple Sclerosis is indicated for bedside clinical practice to support Assesses MS disease progression based on patient's ambulatory ability. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with acute neurological deficits, acute ischemic stroke, intracranial hemorrhage, seizures, or altered mental status. Clinical application is indicated across Comprehensive stroke centers, acute neurovascular units, neuro-ICU, and emergency neurology services.

Limitations & Contraindications

Stroke mimics including severe hypoglycemia, Todd postictal paresis, and hemiplegic migraine must be ruled out prior to intravenous thrombolysis.

Clinical Pearls & Action Plan

Time is brain; rapid determination of Last Known Well time and baseline functional status dictates reperfusion eligibility. Guideline pearl: Can be used for therapeutic decision-making and monitoring treatment response.

Formula & Variables:

Direct mapping of patient's ambulatory ability to corresponding Disease Steps category (0-6 or U for unclassifiable)

Input Parameters

NameTypeRequiredDescription
disease_stepstringYesPatient's current disease step based on ambulatory ability assessment

Score Interpretation & Guidance

RangeStageDescription
0–0NormalNormal function
1–1Mild disabilityMild symptoms or signs
2–2Moderate disabilityVisible abnormality of gait
3–3Early caneIntermittent unilateral support
4–4Late caneDependent on unilateral support
5–5Bilateral supportRequires bilateral support
6–6WheelchairConfined to wheelchair

Evidence-Based References (EBM)

  • Hohol MJ, Orav EJ, Weiner HL. Disease steps in multiple sclerosis: a simple approach to evaluate disease progression. Neurology. 1995 Feb;45(2):251-5. doi: 10.1212/wnl.45.2.251.DOI: 10.1212/wnl.45.2.251
  • Learmonth YC, Motl RW, Sandroff BM, Pula JH, Cadavid D. Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis. BMC Neurol. 2013 Apr 25;13:37. doi: 10.1186/1471-2377-13-37.DOI: 10.1186/1471-2377-13-37
  • Hohol MJ, Orav EJ, Weiner HL. Disease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression. Mult Scler. 1999 Oct;5(5):349-54. doi: 10.1177/135245859900500508.DOI: 10.1177/135245859900500508

Related calculators